Noticias y Actividades de Ferring Pharmaceuticals
Presencia
Sede: Suiza
Ejecutivos
Ver el organigrama con sus 42 ejecutivos principales
Biografías más buscadas en Ferring Pharmaceuticals
- Jean-Frédéric Paulsen, Executive Chairman of the Board and Chief...
- Lars Rebien Sorensen, Vice Chairman of the Board
- Frederik Paulsen, Director
Recientes movimientos de ejecutivos en Ferring Pharmaceuticals
- Krishnakumar N, se ha incorporado a la empresa como Director, External Manufacturing Network (noticia publicada el 13 de abril de 2026).
- Armin Metzger, Executive Vice President and Chief Technical Operations Officer, abandonará la empresa el 1 de abr.. de 2026 (noticia publicada el 27 de marzo de 2026).
- Luzi von Bidder, Director, ha dejado la empresa (noticia publicada el 27 de marzo de 2026).
Haga clic aquí para ver otros movimientos en Ferring Pharmaceuticals
Crear su alerta
para seguir los movimientos de los ejecutivos en Ferring Pharmaceuticals.
Farmacia
Ferring Pharmaceuticals tiene 1.920 competidores entre los que se incluyen Sanofi (Francia), Moderna (Estados Unidos) y Eli Lilly (Estados Unidos).
Popular M&A news in Farmacia
- Vertex Pharmaceuticals has announced the acquisition of Crinetics Pharmaceuticals (publicado el 7 de julio de 2026).
- Novartis has announced the acquisition of Myricx Bio (publicado el 6 de julio de 2026).
- Ipsen has announced the acquisition of Kartos Therapeutics (publicado el 3 de julio de 2026).
Otros contactos sugeridos en el sector Farmacia
Noticias
Últimos comunicados de prensa de Ferring Pharmaceuticals
- Press releases - Ferring Pharmaceuticals
- Press releases - Ferring Pharmaceuticals
- PRESS RELEASE 2020 Archives - Ferring Pharmaceuticals
- Press releases - Ferring Pharmaceuticals
- PRESS RELEASE 2020 Archives - Ferring Pharmaceuticals
- Press releases - Ferring Corporate
- Rebiotix, a Ferring Company, Completes Enrollment for First-Ever, Pivotal Phase 3 Clinical Trial of Microbiota-based RBX2660 - Ferring Corporate
- Ferring’s Propess® is the first pharmacological treatment for cervical ripening to be approved in Japan for over 20 years - Ferring Corporate
- FerGene Appoints David Meek Chief Executive Officer - Ferring Corporate
- FerGene announces pivotal Phase 3 study of nadofaragene firadenovec met its primary endpoint with more than half of patients with high-grade non-muscle invasive bladder cancer (CIS ± Ta/T1) achieving a complete response at three months - Ferring Corporate
- View more press releases Close
Redes sociales sobre Ferring Pharmaceuticals
- Ferring Pharmaceuticals en Wikipedia, Google News y Yahoo Finance
- Ferring Pharmaceuticals en LinkedIn, Twitter y YouTube
